UK markets closed

Omega Therapeutics, Inc. (OMGA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.5800-0.1800 (-6.52%)
At close: 04:00PM EDT
2.6600 +0.08 (+3.10%)
Pre-market: 07:10AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,094
3,094
2,073
144
0
Operating expenses
Research development
77,169
77,169
81,167
47,865
21,063
Selling general and administrative
26,186
26,186
23,672
16,603
6,236
Total operating expenses
103,355
103,355
104,839
66,176
28,645
Operating income or loss
-100,261
-100,261
-102,766
-66,032
-28,645
Interest expense
-
-
-
910
777
Total other income/expenses net
23
23
-157
-1,338
-25
Income before tax
-97,428
-97,428
-102,701
-68,280
-29,447
Income from continuing operations
-97,428
-97,428
-102,701
-68,280
-29,447
Net income
-97,428
-97,428
-102,701
-68,280
-29,447
Net income available to common shareholders
-97,428
-97,428
-102,701
-68,280
-29,447
Basic EPS
-2.08
-
-2.14
-3.05
-0.95
Diluted EPS
-2.08
-
-2.14
-3.05
-0.95
Basic average shares
52,225
-
47,881
22,404
31,126
Diluted average shares
52,225
-
47,881
22,404
31,126